PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion

PharmaEssentia has hired Eric Vogel as its new U.S. Head of Commercialization as it seeks to broaden the label of its rare blood cancer drug Besremi to a much wider market.